CONMED
CNMD
159 hedge funds and large institutions have $1.16B invested in CONMED in 2016 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 54 reducing their positions, and 13 closing their positions.
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
4% more funds holding
Funds holding: 153 → 159 (+6)
7% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 54
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $419K | Put options by funds: $419K
5% less capital invested
Capital invested by funds: $1.22B → $1.16B (-$60M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
+$93.4M |
| 2 |
Goldman Sachs
New York
|
+$19.8M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$18.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$74.4M |
| 2 |
VAM
Visium Asset Management
New York
|
-$10.6M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$3.61M |
| 4 |
AP
AHL Partners
London,
United Kingdom
|
-$3.04M |
| 5 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
-$2.93M |
CNMD Hedge Fund Activity: Q1 2016 in Review
159 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q1 2016, worth a combined $1.16B — down 4.9% from $1.22B a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new CNMD positions and 13 closed out — a net gain of 7 holders — while 58 added to existing stakes and 54 trimmed.
The largest buyer was Scopia Capital Management, opening a new position worth an estimated $93.4M. The largest seller was Fidelity Investments, cutting an estimated $74.4M.
- 159 institutional investors held CONMED (CNMD) as of Q1 2016, up from 153 in Q4 2015.
- Funds reported $1.16B of CONMED stock for Q1 2016, down 4.9% quarter-over-quarter.
- 20 funds opened new CONMED positions in Q1 2016 and 13 closed out, a net change of +7 holders.
- The largest CONMED buyer in Q1 2016 was Scopia Capital Management, an estimated $93.4M added.
- The largest CONMED seller in Q1 2016 was Fidelity Investments, an estimated $74.4M sold.
Based on aggregated 13F filings for Q1 2016.